Expanding Patient Coverage for TCR-T Therapies by Broadening HLA Type Targeting

Time: 9:30 am
day: Day Two


• Application of TargetScan discovery platform to diverse HLA types for novel target epitope identification
• Using ReceptorScan to identify lead TCRs for novel HLA epitopes
• Leveraging proprietary human proteome libraries across diverse HLAs to assess potential off-target safety risks for TCRs